In hepatic diseases (A) Both the bound iron and total iron binding capacity of the plasma may be low (B) Both the bound iron and total iron binding capacity of the plasma may be high (C) Only bound iron may be high (D) Only the total iron binding capacity may be high

In hepatic diseases (A) Both the bound iron and total iron binding capacity of the plasma may be low (B) Both the bound iron and total iron binding capacity of the plasma may be high (C) Only bound iron may be high (D) Only the total iron binding capacity may be high
by

1 Answer

Answer :

Answer : A
by
selected

Related questions

In iron deficiency anemia (A) The plasma bound iron is low (B) The plasma bound iron is high (C) Total iron binding capacity is low (D) Both the plasma bound iron and total iron binding capacity are low

Description : In iron deficiency anemia (A) The plasma bound iron is low (B) The plasma bound iron is high (C) Total iron binding capacity is low (D) Both the plasma bound iron and total iron binding capacity are low

Last Answer : Answer : A

Menke’s disease (Kinky or steel hair disease) is a X-linked disease characterized by (A) High levels of plasma copper (B) High levels of ceruloplasmin (C) Low levels of plasma copper and of ceuloplasmin (D) High level of hepatic copper

Description : Menke’s disease (Kinky or steel hair disease) is a X-linked disease characterized by (A) High levels of plasma copper (B) High levels of ceruloplasmin (C) Low levels of plasma copper and of ceuloplasmin (D) High level of hepatic copper

Last Answer : Answer : C

The normal content of protein bound iron (PBI) in the plasma of males is (A) 120–140 µg/100 ml (B) 200–300 µg/100 ml (C) 120–140 µg/100 ml (D) 200–300 µg/100 ml

Description : The normal content of protein bound iron (PBI) in the plasma of males is (A) 120–140 µg/100 ml (B) 200–300 µg/100 ml (C) 120–140 µg/100 ml (D) 200–300 µg/100 ml

Last Answer : Answer : A

The only correct statement about hormone receptors is (A) Receptors for protein hormones are present in cytosol (B) Receptors for steroid hormones are membrane bound (C) Hormone-receptor binding is irreversible (D) Receptors can undergo down regulation and up regulatoin

Description : The only correct statement about hormone receptors is (A) Receptors for protein hormones are present in cytosol (B) Receptors for steroid hormones are membrane bound (C) Hormone-receptor binding is irreversible (D) Receptors can undergo down regulation and up regulatoin

Last Answer : Answer : D

Retinol and Retinol binding protein are bound with this protein: (A) Albumin (B) Prealbumin (C) α-globulin (D) β-globulin

Description : Retinol and Retinol binding protein are bound with this protein: (A) Albumin (B) Prealbumin (C) α-globulin (D) β-globulin

Last Answer : Answer : B

Retinol and retinol –binding protein (RBP) bound with this protein: (A) Albumin (B) Prealbumin (C) α2-globulin (D) β-globulin

Description : Retinol and retinol –binding protein (RBP) bound with this protein: (A) Albumin (B) Prealbumin (C) α2-globulin (D) β-globulin

Last Answer : Answer : B

Retinol is transported in blood bound to (A) Aporetinol binding protein (B) α2-Globulin (C) β-Globulin (D) Albumin

Description : Retinol is transported in blood bound to (A) Aporetinol binding protein (B) α2-Globulin (C) β-Globulin (D) Albumin

Last Answer : Answer : A

An increased serum ‘Iron’ and decreased ‘Fe’ binding capacity are found in (A) Fe-deficiency anaemia (B) Sideroblastic anaemia (C) Thalassaemia (D) Anaemia of chromic disorders

Description : An increased serum ‘Iron’ and decreased ‘Fe’ binding capacity are found in (A) Fe-deficiency anaemia (B) Sideroblastic anaemia (C) Thalassaemia (D) Anaemia of chromic disorders

Last Answer : Answer : B

An increased serum iron and decreased iron binding capacity is found in (A) Fe deficiency anemia (B) Sideroblastic anemia (C) Folate deficiency anemia (D) Sickle cell anemia

Description : An increased serum iron and decreased iron binding capacity is found in (A) Fe deficiency anemia (B) Sideroblastic anemia (C) Folate deficiency anemia (D) Sickle cell anemia

Last Answer : Answer : B

Iron sorbitol-citric acid differs from iron dextran in that: A. It cannot be injected i.v. B. It is not excreted in urine C. It is not bound to transferrin in plasma D. It produces fewer side effects

Description : Iron sorbitol-citric acid differs from iron dextran in that: A. It cannot be injected i.v. B. It is not excreted in urine C. It is not bound to transferrin in plasma D. It produces fewer side effects

Last Answer : A. It cannot be injected i.v

The following attribute of a drug tends to reduce its volume of distribution: A. High lipid solubility B. Low ionisation at physiological pH values C. High plasma protein binding D. High tissue binding

Description : The following attribute of a drug tends to reduce its volume of distribution: A. High lipid solubility B. Low ionisation at physiological pH values C. High plasma protein binding D. High tissue binding

Last Answer : C. High plasma protein binding

The following attribute of a drug tends to reduce its volume of distribution: A. High lipid solubility B. Low ionisation at physiological pH values C. High plasma protein binding D. High tissue binding

Description : The following attribute of a drug tends to reduce its volume of distribution: A. High lipid solubility B. Low ionisation at physiological pH values C. High plasma protein binding D. High tissue binding

Last Answer : C. High plasma protein binding

The following attribute of a drug tends to reduce its volume of distribution: A. High lipid solubility B. Low ionisation at physiological pH values C. High plasma protein binding D. High tissue binding

Description : The following attribute of a drug tends to reduce its volume of distribution: A. High lipid solubility B. Low ionisation at physiological pH values C. High plasma protein binding D. High tissue binding

Last Answer : C. High plasma protein binding

The plasma protein bound fraction of a drug: A. Contributes to the response at the given moment B. Remains constant irrespective of the total drug concentration C. Remains constant irrespective of the disease state D. Is not available for metabolism unless actively extracted by the liver

Description : The plasma protein bound fraction of a drug: A. Contributes to the response at the given moment B. Remains constant irrespective of the total drug concentration C. Remains constant irrespective of the disease state D. Is not available for metabolism unless actively extracted by the liver

Last Answer : D. Is not available for metabolism unless actively extracted by the liver

The plasma protein bound fraction of a drug: A. Contributes to the response at the given moment B. Remains constant irrespective of the total drug concentration C. Remains constant irrespective of the disease state D. Is not available for metabolism unless actively extracted by the liver

Description : The plasma protein bound fraction of a drug: A. Contributes to the response at the given moment B. Remains constant irrespective of the total drug concentration C. Remains constant irrespective of the disease state D. Is not available for metabolism unless actively extracted by the liver

Last Answer : D. Is not available for metabolism unless actively extracted by the liver

The plasma protein bound fraction of a drug: A. Contributes to the response at the given moment B. Remains constant irrespective of the total drug concentration C. Remains constant irrespective of the disease state D. Is not available for metabolism unless actively extracted by the liver

Description : The plasma protein bound fraction of a drug: A. Contributes to the response at the given moment B. Remains constant irrespective of the total drug concentration C. Remains constant irrespective of the disease state D. Is not available for metabolism unless actively extracted by the liver

Last Answer : D. Is not available for metabolism unless actively extracted by the liver

The ‘free fatty acids’ (FFA) of plasma: (A) metabolically inert (B) mainly bound to β-lipoproteins (C) stored in the fat (D) mainly bound to serum albumin

Description : The ‘free fatty acids’ (FFA) of plasma: (A) metabolically inert (B) mainly bound to β-lipoproteins (C) stored in the fat (D) mainly bound to serum albumin

Last Answer : Answer : D

Free fatty acids of plasma are bound to what?

Description : Free fatty acids of plasma are bound to what?

Last Answer : Bound to serum albumin.

Transdermal drug delivery systems offer the following advantages except: A. They produce high peak plasma concentration of the drug B. They produce smooth and nonfluctuating plasma concentration of the drug C. They minimise interindividual variations in the achieved plasma drug concentration D. They avoid hepatic first-pass metabolism of the drug

Description : Transdermal drug delivery systems offer the following advantages except: A. They produce high peak plasma concentration of the drug B. They produce smooth and nonfluctuating plasma concentration of the ... the achieved plasma drug concentration D. They avoid hepatic first-pass metabolism of the drug

Last Answer : A. They produce high peak plasma concentration of the drug

Transdermal drug delivery systems offer the following advantages except: A. They produce high peak plasma concentration of the drug B. They produce smooth and nonfluctuating plasma concentration of the drug C. They minimise interindividual variations in the achieved plasma drug concentration D. They avoid hepatic first-pass metabolism of the drug

Description : Transdermal drug delivery systems offer the following advantages except: A. They produce high peak plasma concentration of the drug B. They produce smooth and nonfluctuating plasma concentration of the ... the achieved plasma drug concentration D. They avoid hepatic first-pass metabolism of the drug

Last Answer : A

If a drug has a constant bioavailability and first order elimination, its maintenance dose rate will be directly proportional to its: A. Volume of distribution B. Plasma protein binding C. Lipid solubility D. Total body clearance

Description : If a drug has a constant bioavailability and first order elimination, its maintenance dose rate will be directly proportional to its: A. Volume of distribution B. Plasma protein binding C. Lipid solubility D. Total body clearance

Last Answer : D. Total body clearance

If a drug has a constant bioavailability and first order elimination, its maintenance dose rate will be directly proportional to its: A. Volume of distribution B. Plasma protein binding C. Lipid solubility D. Total body clearance

Description : If a drug has a constant bioavailability and first order elimination, its maintenance dose rate will be directly proportional to its: A. Volume of distribution B. Plasma protein binding C. Lipid solubility D. Total body clearance

Last Answer : D. Total body clearanc

Atherosclerosis and coronary heart diseases are associated with the diet: (A) High in total fat and saturated fat (B) Low in protein (C) High in protein (D) High in carbohydrate

Description : Atherosclerosis and coronary heart diseases are associated with the diet: (A) High in total fat and saturated fat (B) Low in protein (C) High in protein (D) High in carbohydrate

Last Answer : Answer : A

In water bound macadam roads, binding material, is (A) Sand (B) Stone dust (C) Cement(D) Brick dust

Description : In water bound macadam roads, binding material, is (A) Sand (B) Stone dust (C) Cement (D) Brick dust

Last Answer : Answer: Option B

Menadione (vitamin K3) can produce kernicterus in neonates by: A. Inducing haemolysis B. Inhibiting glucuronidation of bilirubin C. Displacing plasma protein bound bilirubin D. Both ‘A’ and ‘B’ are correct

Description : Menadione (vitamin K3) can produce kernicterus in neonates by: A. Inducing haemolysis B. Inhibiting glucuronidation of bilirubin C. Displacing plasma protein bound bilirubin D. Both ‘A’ and ‘B’ are correct

Last Answer : D. Both ‘A’ and ‘B’ are correct

In which diseases of the following organs, isoenzymes LDH-1 and LDH-2 will be released in plasma? (A) Kidney, R.B.C and Liver (B) Heart, Kidney and R.B.C (C) Heart, Kidney and Liver (D) Heart, Lungs and Brain

Description : In which diseases of the following organs, isoenzymes LDH-1 and LDH-2 will be released in plasma? (A) Kidney, R.B.C and Liver (B) Heart, Kidney and R.B.C (C) Heart, Kidney and Liver (D) Heart, Lungs and Brain

Last Answer : Answer : B

In allergic diseases, the concentration of the following is increased in plasma: (A) IgA (B) IgG (C) IgD (D) IgE

Description : In allergic diseases, the concentration of the following is increased in plasma: (A) IgA (B) IgG (C) IgD (D) IgE

Last Answer : Answer : D

A 55-year-old male undergoes a total abdominal colectomy. Which of the following statement(s) is/are true concerning the hormonal response to the surgical procedure? a. Adrenocorticotropic hormone (ACTH) is secreted from the anterior pituitary gland b. ACTH stimulation results in elevation of serum cortisol levels for up to a week after the operation c. An increased secretion of aldosterone and ADH may contribute to postoperative fluid retention d. An increase in serum insulin and a fall in glucagon accelerate hepatic glucose production and maintain gluconeogenesis

Description : A 55-year-old male undergoes a total abdominal colectomy. Which of the following statement(s) is/are true concerning the hormonal response to the surgical procedure? a. Adrenocorticotropic ... in serum insulin and a fall in glucagon accelerate hepatic glucose production and maintain gluconeogenesis

Last Answer : Answer: a, c One of the earliest consequence of a surgical procedure is the rise in levels of circulating cortisol that occur in response to a sudden outpouring of ACTH ... hepatic glucose production, and, with other hormones (epinephrine and glucocorticoids), gluconeogenesis is maintained

The distinctive feature(s) of methadone compared to morphine is/are: A. High oral bioavailability B. High plasma protein and tissue binding C. Delayed and milder withdrawal symptoms in dependent subjects D. All of the above

Description : The distinctive feature(s) of methadone compared to morphine is/are: A. High oral bioavailability B. High plasma protein and tissue binding C. Delayed and milder withdrawal symptoms in dependent subjects D. All of the above

Last Answer : D. All of the above

High plasma protein binding: A. Increases volume of distribution of the drug B. Facilitates glomerular filtration of the drug C. Minimises drug interactions D. Generally makes the drug long acting

Description : High plasma protein binding: A. Increases volume of distribution of the drug B. Facilitates glomerular filtration of the drug C. Minimises drug interactions D. Generally makes the drug long acting

Last Answer : D. Generally makes the drug long acting

High plasma protein binding: A. Increases volume of distribution of the drug B. Facilitates glomerular filtration of the drug C. Minimises drug interactions D. Generally makes the drug long acting

Description : High plasma protein binding: A. Increases volume of distribution of the drug B. Facilitates glomerular filtration of the drug C. Minimises drug interactions D. Generally makes the drug long acting

Last Answer : D. Generally makes the drug long acting

High plasma protein binding: A. Increases volume of distribution of the drug B. Facilitates glomerular filtration of the drug C. Minimises drug interactions D. Generally makes the drug long acting

Description : High plasma protein binding: A. Increases volume of distribution of the drug B. Facilitates glomerular filtration of the drug C. Minimises drug interactions D. Generally makes the drug long acting

Last Answer : D. Generally makes the drug long acting

Lesch-Nyhan syndrome, the sex linked, recessive absence of HGPRTase, may lead to (A) Compulsive self destructive behaviour with elevated levels of urate in serum (B) Hypouricemia due to liver damage (C) Failure to thrive and megaloblastic anemia (D) Protein intolerance and hepatic encephalopathy

Description : Lesch-Nyhan syndrome, the sex linked, recessive absence of HGPRTase, may lead to (A) Compulsive self destructive behaviour with elevated levels of urate in serum (B) Hypouricemia due to liver damage (C) Failure to thrive and megaloblastic anemia (D) Protein intolerance and hepatic encephalopathy

Last Answer : Answer : A

Iron absorption is hampered by (A) In achlorhydria (B) When ferritin content of intestinal mucosa is low (C) When saturation of plasma transferring is low (D) When erythropoietic activity is increased

Description : Iron absorption is hampered by (A) In achlorhydria (B) When ferritin content of intestinal mucosa is low (C) When saturation of plasma transferring is low (D) When erythropoietic activity is increased

Last Answer : Answer : A

Herbicides are more tightly bound to soils under which of the condition a). Field capacity b). Saturated c). Both a and b d). Dry

Description : Herbicides are more tightly bound to soils under which of the condition a). Field capacity b). Saturated c). Both a and b d). Dry

Last Answer : d). Dry

The following are true about fluorescein sodium: a. it is 60% bound to the plasma protein b. it leaks out of the choriocapillaris readily c. is excreted mainly by the kidney d. it is excited by green light

Description : The following are true about fluorescein sodium: a. it is 60% bound to the plasma protein b. it leaks out of the choriocapillaris readily c. is excreted mainly by the kidney d. it is excited by green light

Last Answer : is excreted mainly by the kidney

The following drug displaces plasma protein bound phenytoin as well as decreases its metabolism: A. Carbamazepine B. Sodium valproate C. Cimetidine D. Chloramphenicol

Description : The following drug displaces plasma protein bound phenytoin as well as decreases its metabolism: A. Carbamazepine B. Sodium valproate C. Cimetidine D. Chloramphenicol

Last Answer : B. Sodium valproate

riiodothyronine differs from thyroxine in that: A. It is more avidly bound to plasma proteins B. It has a shorter plasma half life C. It is less potent D. It has a longer latency of action

Description : riiodothyronine differs from thyroxine in that: A. It is more avidly bound to plasma proteins B. It has a shorter plasma half life C. It is less potent D. It has a longer latency of action

Last Answer : B. It has a shorter plasma half life

17.2 Triiodothyronine differs from thyroxine in that: A. It is more avidly bound to plasma proteins B. It has a shorter plasma half life C. It is less potent D. It has a longer latency of action (

Description : 17.2 Triiodothyronine differs from thyroxine in that: A. It is more avidly bound to plasma proteins B. It has a shorter plasma half life C. It is less potent D. It has a longer latency of action (

Last Answer : B. It has a shorter plasma half life

Weakly acidic drugs: A. Are bound primarily to α1 acid glycoprotein in plasma B. Are excreted faster in alkaline urine C. Are highly ionized in the gastric juice D. Do not cross blood-brain barrier

Description : Weakly acidic drugs: A. Are bound primarily to α1 acid glycoprotein in plasma B. Are excreted faster in alkaline urine C. Are highly ionized in the gastric juice D. Do not cross blood-brain barrier

Last Answer : B. Are excreted faster in alkaline urine

Marked redistribution is a feature of: A. Highly lipid soluble drugs B. Poorly lipid soluble drugs C. Depot preparations D. Highly plasma protein bound drugs

Description : Marked redistribution is a feature of: A. Highly lipid soluble drugs B. Poorly lipid soluble drugs C. Depot preparations D. Highly plasma protein bound drugs

Last Answer : A. Highly lipid soluble drugs

Weakly acidic drugs: A. Are bound primarily to α1 acid glycoprotein in plasma B. Are excreted faster in alkaline urine C. Are highly ionized in the gastric juice D. Do not cross blood-brain barrier

Description : Weakly acidic drugs: A. Are bound primarily to α1 acid glycoprotein in plasma B. Are excreted faster in alkaline urine C. Are highly ionized in the gastric juice D. Do not cross blood-brain barrier

Last Answer : B. Are excreted faster in alkaline urine

Marked redistribution is a feature of: A. Highly lipid soluble drugs B. Poorly lipid soluble drugs C. Depot preparations D. Highly plasma protein bound drugs

Description : Marked redistribution is a feature of: A. Highly lipid soluble drugs B. Poorly lipid soluble drugs C. Depot preparations D. Highly plasma protein bound drugs

Last Answer : A. Highly lipid soluble drugs

The distinctive feature of nimesulide is: A. It does not inhibit prostaglandin synthesis B. It does not cause gastric irritation C. It is usually well tolerated by aspirin intolerant asthma patients D. It is not bound to plasma proteins

Description : The distinctive feature of nimesulide is: A. It does not inhibit prostaglandin synthesis B. It does not cause gastric irritation C. It is usually well tolerated by aspirin intolerant asthma patients D. It is not bound to plasma proteins

Last Answer : C. It is usually well tolerated by aspirin intolerant asthma patients

Weakly acidic drugs: A. Are bound primarily to α1 acid glycoprotein in plasma B. Are excreted faster in alkaline urine C. Are highly ionized in the gastric juice D. Do not cross blood-brain barrier

Description : Weakly acidic drugs: A. Are bound primarily to α1 acid glycoprotein in plasma B. Are excreted faster in alkaline urine C. Are highly ionized in the gastric juice D. Do not cross blood-brain barrier

Last Answer : B. Are excreted faster in alkaline urine

Marked redistribution is a feature of: A. Highly lipid soluble drugs B. Poorly lipid soluble drugs C. Depot preparations D. Highly plasma protein bound drugs

Description : Marked redistribution is a feature of: A. Highly lipid soluble drugs B. Poorly lipid soluble drugs C. Depot preparations D. Highly plasma protein bound drugs

Last Answer : A. Highly lipid soluble drugs

All of the following are true of Wilson’s disease except (A) Low total plasma Cu (B) Elevated urinary copper (C) Arthritis (D) Aminoaciduria

Description : All of the following are true of Wilson’s disease except (A) Low total plasma Cu (B) Elevated urinary copper (C) Arthritis (D) Aminoaciduria

Last Answer : Answer : C

The lone pair of electrons at one of the ring nitrogens in the given amino acid makes a potential ligand, which is important in binding the iron atoms in hemoglobin: (A) Tryptophan (B) Threonine (C) Histidine (D) Serine

Description : The lone pair of electrons at one of the ring nitrogens in the given amino acid makes a potential ligand, which is important in binding the iron atoms in hemoglobin: (A) Tryptophan (B) Threonine (C) Histidine (D) Serine

Last Answer : Answer : C

The termination of heparin activity by protamine sulfate is due to (a) A chelating action (b) The inhibition of gastrointestinal absorption of heparin (c) The displacement of heparin-plasma protein binding (d) An acid-base interaction (e) The prothrombin-like activity of protamine

Description : The termination of heparin activity by protamine sulfate is due to (a) A chelating action (b) The inhibition of gastrointestinal absorption of heparin (c) The displacement of heparin-plasma protein binding (d) An acid-base interaction (e) The prothrombin-like activity of protamine

Last Answer : Ans: D

True statements about the pH of the extracellular fluid: a. in healthy people it is maintained between 7.4 and 7.5 b. is increased in hypovolaemic shock c. decreases following a cardiac arrest d. influences the binding of drugs to plasma proteins

Description : True statements about the pH of the extracellular fluid: a. in healthy people it is maintained between 7.4 and 7.5 b. is increased in hypovolaemic shock c. decreases following a cardiac arrest d. influences the binding of drugs to plasma proteins

Last Answer : . influences the binding of drugs to plasma proteins